IGF-1 LR3 vs HGH: What the Research Shows
IGF-1 LR3 and HGH side by side: what they are, how they are regulated and what is still unknown.
Where the research points
Consider IGF-1 LR3 if…
No sourced contrast for this side yet. We add a point here only when it is tied to a study or label.
Consider HGH if…
- you want products with an FDA label: Genotropin (somatropin) is indicated for children with growth failure from inadequate growth hormone secretion[7]
- you want randomized data in adults with growth hormone deficiency: Within 3 months lean body mass rose 5.09% and body fat fell 10.89%; waist fell 1.42%.[14]
What they have in common
- Only animal or lab studies of IGF-1 LR3 were found (e.g. rat): The IGF-I variants were 2.5-3 times more potent than IGF-I at restoring growth in diabetic rats.[12]
Spec comparison
Showing 8 of 10 fields where the two differ. Category, PCAC vote, Jul 2026 are the same or both unknown.
| Field | IGF-1 LR3 | HGH |
|---|---|---|
| Class | IGF-1 analog | Recombinant growth hormone |
| Also called | LR3 | GH, growth hormone, generic HGH, IU |
| Category | Growth hormone | Growth hormone |
| FDA status | Not FDA approved · research chemical | FDA approved (prescription only) |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | Not on the Jul 2026 agenda |
| WADA | Prohibited by WADA (S2.3)IGF-1 and its analogues (LR3 is an IGF-1 analogue) are prohibited in S2.3, at all times. | Prohibited by WADA (S2.2.3)Growth hormone and its analogues and fragments are prohibited at all times (S2.2.3). |
| Half-life | 563 min half-life in wound fluid (versus 872 min for IGF-I)wound chamber (rat) (rat) · The American journal of physiology 1999, PMID 10198302 | 0.4 hours IV; 3.0 hours subcutaneousintravenous (normal adults); subcutaneous (GHD adults), Genotropin · FDA label (Genotropin) |
| Evidence strength | Human observational evidence, 3 of 4Strongest: Growth hormone & IGF research 2010, PMID 20675162 | Human RCT evidence, 4 of 4Strongest: Journal of applied physiology 2014, PMID 24235105 |
| Human studies we summarised | 1 human (0 randomized or controlled) of 12 summarised | 13 human (13 randomized or controlled) of 20 summarised |
| Typical study doses |
|
|
Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.
IGF-1 LR3 and HGH together
People also search for this pair as a stack. The stack page covers timing and interaction questions as they are sourced. Evidence for the combination: No studies tested these together (PubMed search: 0 results, 2 Oct 2026).
A modified IGF-1 versus the hormone that makes IGF-1
A rat study compared IGF-I with two variants that bind poorly to IGF-binding proteins.[12]
In GH-deficient adults, a long GH replacement study measured body composition by impedance and well-being by questionnaire.[14]
In rats, LR3-IGF-I but not IGF-I increased body weight and wet intestinal tissue weight by about 20%.[15]
In tumor-bearing rats, LR3-IGF-I had no positive effect on carcass protein accretion, alone or combined with insulin.[16]
Safety signals and label status
Genotropin carries a label with specific warnings, including that somatropin should not be used with progression or recurrence of an underlying intracranial tumor.[7]
A growth-hormone trial in older men found that bodily pain increased with GH alone.[17]
IGF-1 LR3 is not an approved drug, and its human link is a black-market product analysis that notes the His-tagged peptide may be a by-product from biochemical studies rather than something synthesized for injection.[3]
Common questions
IGF-1 LR3 vs HGH: which builds more muscle?
Only growth hormone has human trials, and in healthy fit young people lean body mass rose without clear strength gains. IGF-1 LR3 has no human muscle study.[18]
Is IGF-1 LR3 a type of growth hormone?
No. IGF-1 LR3 is a variant of IGF-I; the cached rat work tested IGF-I variants that bind IGF-binding proteins poorly.[12]
Is HGH FDA approved?
Yes, for specific conditions, as shown by Genotropin's label.[7]
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions.The American journal of physiology · 1999PMID 10198302Accessed 2 Oct 2026
- 3Detection of His-tagged Long-R³-IGF-I in a black market product.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2010PMID 20675162Accessed 2 Oct 2026
- 4IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep.American journal of physiology. Endocrinology and metabolism · 2025PMID 39679943Accessed 2 Oct 2026
- 5Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.Journal of Alzheimer's disease : JAD · 2025PMID 39610283Accessed 2 Oct 2026
- 6Insulin-like growth factor-I and analogues increase growth in artificially-reared neonatal pigs.The British journal of nutrition · 2002PMID 12067429Accessed 2 Oct 2026
- 7GENOTROPIN (SOMATROPIN) KIT [PFIZER LABORATORIES DIV PFIZER INC]FDA label (Genotropin), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 8Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation.Journal of applied physiology (Bethesda, Md. : 1985) · 2014PMID 24235105Accessed 2 Oct 2026
- 9Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin.European journal of endocrinology · 2013PMID 23447518Accessed 2 Oct 2026
- 10Local administration of growth hormone stimulates tendon collagen synthesis in elderly men.Journal of applied physiology (Bethesda, Md. : 1985) · 2012PMID 22961272Accessed 2 Oct 2026
- 11PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR "recombinant growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone therapy"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone administration"[tiab] OR "GH therapy"[tiab] OR "GH treatment"[tiab] OR "GH replacement"[tiab] OR "GH administration"[tiab] OR "growth hormone injection"[tiab] OR "growth hormone injections"[tiab] OR "growth hormone supplementation"[tiab]) AND ("Long R3"[tiab] OR (LR3[tiab] AND (IGF[tiab] OR "IGF-1"[tiab] OR "IGF-I"[tiab] OR "insulin-like growth factor"[tiab])))PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.The Biochemical journal · 1993PMID 7683875Accessed 2 Oct 2026
- 13Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.The Journal of clinical endocrinology and metabolism · 2005PMID 15784718Accessed 2 Oct 2026
- 14Two years of replacement therapy in adults with growth hormone deficiency.Clinical endocrinology · 1997PMID 9404448Accessed 2 Oct 2026
- 15Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.Gut · 1995PMID 8549937Accessed 2 Oct 2026
- 16Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.The Biochemical journal · 1994PMID 8053901Accessed 2 Oct 2026
- 17The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial.The Journal of clinical endocrinology and metabolism · 2006PMID 16332938Accessed 2 Oct 2026
- 18Systematic review: the effects of growth hormone on athletic performance.Annals of internal medicine · 2008PMID 18347346Accessed 2 Oct 2026
Found an error? Report a correction.